The researchers found that autistic men without a learning...
Category:
Health
Latest
Medicines for four rare diseases become cheaper due to domestic production
Four more drugs for three diseases - Tablet Sapropterin for...
Closely monitoring outbreak of H9N2, clusters of respiratory illness in children in China: Govt
There is a low risk to India from both the avian influenza --...
General insurers seek cooperation from hospitals for faster settlement Covid-19 claims
The insurance companies are ready to extend their maximum cooperation to hospitals in completing the discharge process in the quickest possible time in all cashless claims as per the HC directives and solicit the kind cooperation of all hospitals in this regard, said Atul Sahai, chairman of GI Council and CMD of New India Assurance, the largest general insurer in the country.
Indian airlines may post $4.1 billion consolidated loss this fiscal: CAPA
“We expect that Indian airlines will lose a consolidated USD 4.1-billion in FY2022, similar to that in FY2021. This will take total losses over two years to around USD 8 billion as a result of the two COVID-19 waves,” CAPA said in the report.
Epillo launches the first-of-its-kind integrated mobile App for patients
There are special features available that will aid in the global battle against COVID-19, where patient’s symptom data is captured, digitized, monitored, and analyzed and can be shared with their doctors. Through this feature, doctors can also prescribe medication to their patients using their clinical platform. So far, there are more than 200 doctors on board to support the telemedicine feature for this app and they will be gradually ramping up these numbers in the coming future.
Top Ayurveda institute incorporates allopathy, modern tech; successfully treats 600 Covid patients
Prof Tanuja Nesari said a holistic approach and the integration of ayurveda, allopathy and modern diagnostic technology made it possible.
Summit secures additional $2.4 bln for COVID shots for poor countries
The funds will allow COVAX to secure 1.8 billion fully subsidised doses for delivery to lower-income countries in 2021 and early 2022, enough to protect 30% of adults in those nations, GAVI said in a statement.
“We have taken a big step towards ‘one world protected’,” said Jose Manuel Barroso, GAVI chairman. The fresh funds brought total COVAX financing to $9.6 billion, he added.
Tapeworm drug, masks are part of Reliance’s plan to tackle coronavirus
Its diagnostic kits — R-Green and R-Green Pro — have been approved by India’s apex medical research body and it has designed a process to make sanitizers at one-fifth the market cost, Reliance said in the report.
Global ”hot spots” where new coronaviruses may emerge identified
“Land use changes can have an important impact on human health, both because we are modifying the environment, and also because they can increase our exposure to zoonotic disease,” said study co-author Paolo D”Odorico, a professor at the University of California, Berkeley in the US.
“Every formal land use change should be evaluated not only for the environmental and social impacts on resources such as carbon stocks, microclimate and water availability, but also for the potential chain reactions that could impact human health,” D’Odorico said.
Government issues guidelines for care of children affected by Covid-19
The states need to identify the children in distress through outreach and surveys and prepare a database with a profile of each child, along with the details of their specific needs and requirements, and ensure that the data is uploaded on the Track Child portal.
The National Commission for Protection of Child Rights (NCPCR), in an affidavit to the Supreme Court, said 9,346 children have lost at least one of the parents to the deadly virus, including over 1,700 who have lost both their parents, according to data received from the states
Covid-19 vaccine: After Pfizer, Serum Institute seeks indemnity, say sources
Earlier last year, SII CEO Adar Poonawala had advocated for indemnity for all vaccine manufacturers.
“We need to have the government indemnify manufacturers, especially vaccine manufacturers, against all lawsuits… Frivolous claims come up and you see in the media something being blown out of proportion. The government needs to step in with the right messaging,” he had said.
Amid the nationwide COVID-19 vaccine crunch, US pharma giant Pfizer is seeking an indemnity bond that will exempt it from legal claims in case there are any adverse effects from the vaccine.
Covid-19 claims cost life reinsurers billions
The biggest costs for life reinsurers came from the US and to a lesser extent the UK and Canada but claims from other countries including South Africa and in Latin America added to the costs. Life reinsurers only have limited exposure to India.
BI estimates Swiss Re accounted for around 35% of claims followed by Reinsurance Group of America on 27% but the decline in deaths should mean much lower claims for the second half of the year.